Scott H. Maurer
Experienced in Leukemia

Dr. Scott H. Maurer

Pediatric Hematology Oncology
UPMC
Pediatric Palliative Medicine And Supportive Care
4401 Penn Avenue, 
Pittsburgh, PA 
On Staff At
Clinical Trials:Currently Recruiting for 2 Trials
Accepting New Patients

Experienced in Leukemia
UPMC
Pediatric Palliative Medicine And Supportive Care
4401 Penn Avenue, 
Pittsburgh, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Scott Maurer, MD, is a pediatric palliative care physician and a pediatric oncologist. Dr. Maurer is certified in pediatrics, pediatric hematology/oncology, and hospice and palliative medicine by the American Board of Pediatrics. He is the chief of the division of palliative medicine and supportive care at UPMC Children’s Hospital of Pittsburgh and is an associate professor of pediatrics at the University of Pittsburgh School of Medicine.

Dr. Maurer is rated as an Experienced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Infantile Neutropenia, Rosai-Dorfman Disease, Leukemia, and Pediatric Low-Grade Glioma (pLGG).

His clinical research consists of co-authoring 37 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Leukemia.

Graduate Institution
Oregon Health Sciences University Hospital
Residency
Seattle Childrens Hospital and Regional Medical Center
Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in PA
Board Certifications
American Board Of Pediatrics
American Board Of Pediatrics
American Board Of Pediatrics
Fellowships
St Jude Children's Research Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Gateway Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • OTHER MEDICARE PART D
Geisinger
  • HMO
  • POS
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
PA Health and Wellness
  • HMO
  • MANAGED MEDICAID PLAN
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 14 Less Insurance Carriers -

Locations

Pediatric Palliative Medicine and Supportive Care
4401 Penn Avenue, Pittsburgh, PA 15224
Call: 412-692-3234

Additional Areas of Focus

Dr. Maurer has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

A Phase II Study of Vaccinations with HLA-A2 Restricted Glioma Antigen Peptides in Combination with Poly-ICLC for Children with Recurrent Unresectable Low-Grade Gliomas (LGG)
A Phase II Study of Vaccinations with HLA-A2 Restricted Glioma Antigen Peptides in Combination with Poly-ICLC for Children with Recurrent Unresectable Low-Grade Gliomas (LGG)
Enrollment Status: Recruiting
Publish Date: January 06, 2025
Intervention Type: Biological
Study Phase: Phase 2
Immunotherapy for Recurrent Ependymomas in Children Using Human Leukocyte Antigen (HLA)-A2 Restricted Tumor Antigen Peptides in Combination with Imiquimod
Immunotherapy for Recurrent Ependymomas in Children Using Human Leukocyte Antigen (HLA)-A2 Restricted Tumor Antigen Peptides in Combination with Imiquimod
Enrollment Status: Recruiting
Publish Date: December 06, 2024
Intervention Type: Other, Biological, Drug
Study Drugs: HLA-A2 Restricted Synthetic Tumor Antigen, Imiquimod
Study Phase: Phase 1
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
A Randomized Phase 3 Study of Vincristine, Dactinomycin, Cyclophosphamide (VAC) Alternating With Vincristine and Irinotecan (VI) Versus VAC/VI Plus Temsirolimus (TORI, Torisel, NSC# 683864) in Patients With Intermediate Risk (IR) Rhabdomyosarcoma (RMS)
Enrollment Status: Active_not_recruiting
Publish Date: December 01, 2025
Intervention Type: Radiation, Drug, Biological, Other
Study Drugs: Cyclophosphamide, Dactinomycin, Irinotecan hydrochloride, Temsirolimus, Vincristine sulfate, Vinorelbine
Study Phase: Phase 3
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides with Poly-ICLC for Children with Newly Diagnosed Malignant Brain Stem Gliomas, Non-Brainstem High-Grade Gliomas, Recurrent Low-Grade Gliomas or Recurrent High Grade Gliomas
A Pilot Study to Evaluate the Effects of Vaccinations with HLA-A2-Restricted Glioma Antigen-Peptides with Poly-ICLC for Children with Newly Diagnosed Malignant Brain Stem Gliomas, Non-Brainstem High-Grade Gliomas, Recurrent Low-Grade Gliomas or Recurrent High Grade Gliomas
Enrollment Status: Completed
Publish Date: December 06, 2024
Intervention Type: Biological
Study Drugs: HLA-A2 Restricted Glioma Antigen Peptides Vaccine, Poly-ICLC
Study Phase: Phase 1
View 2 Less Clinical Trial

37 Total Publications

Erratum: Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced Cancer.
Erratum: Promoting Resilience in Stress Management: A Randomized Controlled Trial of a Novel Psychosocial Intervention for Adolescents and Young Adults With Advanced Cancer.
Journal: JCO oncology practice
Published: October 09, 2025
View All 37 Publications
Similar Doctors
A K. Ritchey
Advanced in Leukemia
Dr. A K. Ritchey
Pediatric Hematology Oncology
Advanced in Leukemia
Dr. A K. Ritchey
Pediatric Hematology Oncology

UPMC Children's Hospital Of Pittsburgh, Pediatric Hematology/Oncology

4401 Penn Avenue, Floor 3, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

A. Kim Ritchey, MD, is a pediatric hematologist/oncologist and is certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics. He is vice-chair of International Affairs of the Department of Pediatrics at UPMC Children’s Hospital of Pittsburgh and is professor of pediatrics at the University of Pittsburgh School of Medicine. He received his medical degree from the University of Cincinnati School of Medicine and completed his pediatric residency at Johns Hopkins Hospital, followed by his fellowship in pediatric hematology/oncology at Yale University. Dr. Ritchey’s clinical interests include all aspects of pediatric hematology and oncology. His career focus is pediatric leukemia and coagulation disorders. He has numerous publications in peer-reviewed journals as well as book chapters and has presented both locally and nationally. He is a member of the American Society of Pediatric Hematology/Oncology where he served as president, as well as the American Society of Hematology, and the American Society of Clinical Oncology. Dr. Ritchey is rated as an Advanced provider by MediFind in the treatment of Leukemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hemophilia B, Hemophilia A, and Leukemia.

Jenny Ruiz
Experienced in Leukemia
Dr. Jenny Ruiz
Pediatric Hematology Oncology
Experienced in Leukemia
Dr. Jenny Ruiz
Pediatric Hematology Oncology

Pediatric Hematology Oncology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances

Jenny Ruiz, MD, specializes in pediatric hematology oncology and is board certified in pediatric hematology-oncology and pediatrics by the American Board of Pediatrics. She practices at UPMC Children's Hospital of Pittsburgh, Pediatric Hematology/Oncology and is affiliated with UPMC Magee-Womens Hospital. Dr. Ruiz completed her fellowship at Children's Hospital of Philadelphia, residency at Columbia University, and medical education at Columbia University College of Physicians and Surgeons. Dr. Ruiz is rated as an Experienced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Leukemia, Acute Lymphoblastic Leukemia (ALL), Ewing Sarcoma, and Osteosarcoma.

Jean M. Tersak
Experienced in Leukemia
Dr. Jean M. Tersak
Pediatric Hematology Oncology
Experienced in Leukemia
Dr. Jean M. Tersak
Pediatric Hematology Oncology

Pediatric Hematology Oncology In Lawrenceville

4401 Penn Avenue, 
Pittsburgh, PA 
 (0.1 miles away)
412-692-5055
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jean M. Tersak, MD, provides care for pediatric oncology patients and long term survivors of childhood cancer at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is institutional principal investigator for the UPMC Children’s Oncology Group and director of clinical oncology research within the Division of Pediatric Hematology/Oncology. She is also a professor of pediatrics and clinical and translational science at the University of Pittsburgh School of Medicine and is board-certified in pediatric hematology/oncology. Dr. Tersak earned her bachelor's degree, master’s degree, and  medical degree from the University of Pittsburgh. She completed her residency and fellowship at UPMC Children’s Hospital of Pittsburgh. Dr. Tersak is extensively involved in clinical research including the evaluation and treatment of patients with new diagnosis. Her research interests include the late effects, quality of life, and neurocognitive outcomes in survivors of childhood cancer and evaluation and treatment of opsoclonus myoclonus in patients with neuroblastoma. She is a member of the American Society of Clinical Oncology Children’s Oncology Group. View the full list of Dr. Tersak’s publications on PubMed. Dr. Tersak is rated as an Advanced provider by MediFind in the treatment of Leukemia. Her top areas of expertise are Neuroblastoma, Reticulohistiocytoma, Histiocytosis, Bone Marrow Aspiration, and Splenectomy.

VIEW MORE LEUKEMIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Maurer's expertise for a condition
ConditionClose
        • Experienced
        • Infantile Neutropenia
          Dr. Maurer is
          Experienced
          . Learn about Infantile Neutropenia.
          See more Infantile Neutropenia experts
        • Langerhans Cell Histiocytosis
          Dr. Maurer is
          Experienced
          . Learn about Langerhans Cell Histiocytosis.
          See more Langerhans Cell Histiocytosis experts
        • Leukemia
          Dr. Maurer is
          Experienced
          . Learn about Leukemia.
          See more Leukemia experts
        • Pediatric Low-Grade Glioma (pLGG)
          Dr. Maurer is
          Experienced
          . Learn about Pediatric Low-Grade Glioma (pLGG).
          See more Pediatric Low-Grade Glioma (pLGG) experts
        • Rosai-Dorfman Disease
          Dr. Maurer is
          Experienced
          . Learn about Rosai-Dorfman Disease.
          See more Rosai-Dorfman Disease experts
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile
        For Patients
        • Our Story
        • How MediFind Works
        • Conditions A-Z
        • Doctor Directory
        • Symptoms Directory
        • Procedures Directory
        • Treatment Directory
        • Drug Directory
        • Infusion Center Finder
        • FAQ
        • Contact Us
        For Providers and Practices
        • Claim Your Profile
        • Newsroom
        Business Solutions
        • Provider
        • Network Solutions
        Additional Resources
        • Consumer Health Data Privacy Policy
        • Privacy Policy
        • Terms of Use
        • Advertising Policy
        • Content Policy
        Subscribe to our newsletter

        Sign up to stay informed about MediFind and get wellness sent your way.

        Close

          By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

          Bullet PinMediFind
          Follow us on
          This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
          © 2026 All Rights Reserved

          Request an Appointment

          If you are experiencing a medical emergency, call 9-1-1.

          MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

          Patient Details

          This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.